Relative to the pricing of generic prescription drugs. This bill requires the commissioner of the Department of Health and Human Services to notify the Department of Justice of certain price increases for essential off-patent or generic drugs. The bill authorizes the Department of Justice to issue a civil investigative demand upon receipt of notification of suspected price gouging or in any other case in which the Department has reasonable cause to believe that unfair price gouging has occurred or is about to occur. The Department of Justice expects the bill to result in an increased number of investigations, with an indeterminable fiscal impact. The Department of Health and Human Services likewise expects an indeterminable cost associated with monitoring and reporting on price increases.